Advicenne Reports Full Year 2018 Financial Results and Confirms Operational Outlook for 2019
March 21th, 2019
Advicenne (Euronext: ADVIC – FR0013296746), a pharmaceutical company specializing in the development of adult and pediatric therapeutic products for the treatment of orphan renal and neurological diseases, announces its financial results for the full year ended December 31, 2018. The late-stage French biopharmaceutical company also confirms its operational outlook for 2019